Akeso Announces Completion of Patient Enrollment in Phase III Clinical Trial for Ivonescimab as First-Line Treatment for Biliary Tract Cancer Compared to PD-L1 Therapy

by | PRNewswire Asia

HONG KONG, Sept. 2, 2025 /PRNewswire/ — Akeso (9926.HK) has recently announced the completion of patient enrollment in its Phase III, multicenter, randomized, controlled, registrational study evaluating ivonescimab, in combination with standard therapy, against...

A Guide to the Hidden Culinary Treasures of Taikoo Area: Discover New Delicacies & Satisfy Your Cravings All Within a 15-Minute Walk in this Gourmet Enclave of the Eastern District

by | PRNewswire Asia

For a limited time only, enjoy dining privileges with Taste Across Taikoo Plus 200 LIVE+ Dollars for DBS credit cardholders#TasteAcrossTAIKOO #CityplazaHK #TaikooPlace #LIVEHAPPY快樂識放  HONG KONG, Sept. 1, 2025 /PRNewswire/ — In a city celebrated for its...

Peak Energy breaks ground in the Philippines with 65 MWp solar project

by | PRNewswire Asia

Solar project to deliver clean energy for decades, supporting decarbonization and energy security in the Philippines MANILA, Philippines, Sept. 2, 2025 /PRNewswire/ — Peak Energy, Asia’s leading clean renewable energy developer and Independent Power...

ApplemagazineHK Teaches You to Easily Master Hair Removal Strategies

by | PRNewswire Asia

HONG KONG, Sept. 2, 2025 /PRNewswire/ — The brand-new online media platform ApplemagazineHK has officially launched, dedicated to providing the most comprehensive and professional beauty medicine and daily care information for young women in Hong Kong. The...

SteriLance Safety Lancets Adopted Across Thailand's Public-Hospital Channels

by | PRNewswire Asia

BANGKOK, Sept. 2, 2025 /PRNewswire/ — SteriLance Medical announced that its safety lancet portfolio — PRESS PLUS, IMPRESS and LITE3 — has been adopted within Thailand’s public-hospital channels following a tender awarded by a nationally recognized...

LOTTE BIOLOGICS establishes contract manufacturing partnership with a leading U.S. Biopharmaceutical Company

by | PRNewswire Asia

Secures third contract this year, reinforcing global competitiveness and expanding strategic partnerships SEOUL, South Korea and SYRACUSE, N.Y., Sept. 2, 2025 /PRNewswire/ — LOTTE BIOLOGICS (CEO James Park) today announced that it has entered a late-stage...